Scaleup Partners
Avda. Manoteras 24, Madrid, 28029, Spain
Overview
We are the local sales partner in Europe and LatAm for technology companies targeting corporates / enterprises. We work as an extension of our clients' own sales team, help them “hunting” and “farming” new corporate clients and stay with them in the long run as KAMs. We also offer fundraising services. From a scouting perspective we have a global approach, with clients in 10+ countries from North and South America, Europe, Asia and Australia from 4.000+ analyzed companies.
- Total investments
- 1
- Lead investments
- 0
- Investments · 12mo
- 0
- Active investors
- 1
Investment portfolio
- AIGEN Sciences
Participated · Equity · Oct 2024
AIGEN Sciences is an AI-driven drug discovery platform that develops small-molecule synthetic drugs targeting intractable diseases with high unmet medical needs. Founded in April 2021 and based in Seoul, the company provides drug research and development services using a proprietary AI platform. Its pipeline includes multiple lead substance optimizations and preclinical candidates. AIGEN aims to advance state-of-the-art AI drug discovery technologies and to transform high-cost, low-efficiency drug discovery into faster, more efficient processes. The company will use the funding to enhance its drug development capabilities and accelerate growth.
Team
Youssouf Traore
Director
LinkedIn